Murine hepatitis caused by lymphocytic choriomeningitis virus. II. Cells involved in pathogenesis. 1995

J Gossmann, and J Lohler, and O Utermohlen, and F Lehmann-Grube
Heinrich-Pette-Institut für Experimentelle Virologie und Immunologie, Universität Hamburg, Germany.

BACKGROUND Human virus hepatitides are often assumed to result from pathogenic immune responses rather than from direct viral cytopathic effects, but the details are largely unknown. Hepatitis of the mouse undergoing infection with lymphocytic choriomeningitis (LCM) virus is an immunopathologic phenomenon, and its analysis may help us to understand some of the events leading to the human illnesses. METHODS Mice were infected with LCM virus and were depleted of T cells or their subsets by inoculation of monoclonal antibodies; other infected mice lacked all T lymphocytes or the CD8+ subset because of genetic defects. Also, mice were infected and transfused with unsorted or CD(4+)-enriched LCM-immune spleen cells. Subsequently, the infectious titers were determined, the cytolytic activities of mononuclear cells isolated from the livers were measured, and the disease process was studied. RESULTS In LCM virus-infected mice devoid of all T lymphocytes, pathologic alterations remained undetectable. In contrast, immunocompetent animals responded with a severe hepatitis, at the height of which the liver contained large numbers of cytolytic mononuclear leukocytes. Experiments with mice depleted of subset T lymphocytes revealed a predominantly CD8+ T lymphocyte-mediated phase, which was characterized by panlobular inflammation, whereas later there was a periportal inflammatory reaction, in which mainly CD4+ T lymphocytes were involved. Infusion of syngeneic immune spleen cells from immunocompetent donor mice into infected thymus-less mice resulted in virus elimination and damage to liver cells. With a similar protocol and the use of congenic mice, CD8+ T lymphocytes were observed to rapidly enter the recipients' livers, where they were present at the time liver cell injury was apparent. In mice genetically deficient in CD8+ T lymphocytes due to disruption of the gene for beta 2-microglobulin, a somewhat different type of LCM hepatitis developed that was largely dependent on CD4+ T lymphocytes. Liver cells were also damaged in infected nude mice that had been infused with positively selected CD4+ spleen cells from infected +/+ mice. CONCLUSIONS Our findings published previously (Löhler J, Gossmann J, Kratzberg T, Lehmann-Grube F. Lab Invest 1994; 70:263-78) and related here suggest that the hepatitis in mice undergoing infection with LCM virus consists of three consecutive phases, which are mediated predominantly by NK cells, CD8+ T lymphocytes, and CD4+ T lymphocytes, respectively. Presumably, other elements of the immune system, such as mononuclear phagocytes and B lymphocytes, contribute to the pathogenesis.

UI MeSH Term Description Entries
D008216 Lymphocytic Choriomeningitis A form of meningitis caused by LYMPHOCYTIC CHORIOMENINGITIS VIRUS. MICE and other rodents serve as the natural hosts, and infection in humans usually occurs through inhalation or ingestion of infectious particles. Clinical manifestations include an influenza-like syndrome followed by stiff neck, alterations of mentation, ATAXIA, and incontinence. Maternal infections may result in fetal malformations and injury, including neonatal HYDROCEPHALUS, aqueductal stenosis, CHORIORETINITIS, and MICROCEPHALY. (From Joynt, Clinical Neurology, 1996, Ch26, pp1-3) Armstrong Syndrome,Armstrong's Syndrome,Encephalomyelitis, Lymphocytic Choriomeningitis Virus,Lymphocytic Choriomeningitis Virus Encephalomyelitis,Choriomeningitis, Lymphocytic,Syndrome, Armstrong,Syndrome, Armstrong's
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D005260 Female Females
D006524 Hepatitis, Viral, Animal INFLAMMATION of the LIVER in animals due to viral infection. Viral Hepatitis, Animal,Animal Viral Hepatitides,Animal Viral Hepatitis,Viral Hepatitides, Animal
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013602 T-Lymphocytes, Cytotoxic Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These CD8-positive cells are distinct from NATURAL KILLER CELLS and NATURAL KILLER T-CELLS. There are two effector phenotypes: TC1 and TC2. Cell-Mediated Lympholytic Cells,Cytotoxic T Cells,Cytotoxic T Lymphocyte,Cytotoxic T-Lymphocytes,TC1 Cell,TC1 Cells,TC2 Cell,TC2 Cells,Cell Mediated Lympholytic Cells,Cell, Cell-Mediated Lympholytic,Cell, TC1,Cell, TC2,Cell-Mediated Lympholytic Cell,Cytotoxic T Cell,Cytotoxic T Lymphocytes,Cytotoxic T-Lymphocyte,Lymphocyte, Cytotoxic T,Lympholytic Cell, Cell-Mediated,Lympholytic Cells, Cell-Mediated,T Cell, Cytotoxic,T Lymphocyte, Cytotoxic,T Lymphocytes, Cytotoxic,T-Lymphocyte, Cytotoxic
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D016176 T-Lymphocyte Subsets A classification of T-lymphocytes, especially into helper/inducer, suppressor/effector, and cytotoxic subsets, based on structurally or functionally different populations of cells. T-Cell Subset,T-Cell Subsets,T-Lymphocyte Subset,Subset, T-Cell,Subset, T-Lymphocyte,Subsets, T-Cell,Subsets, T-Lymphocyte,T Cell Subset,T Cell Subsets,T Lymphocyte Subset,T Lymphocyte Subsets

Related Publications

J Gossmann, and J Lohler, and O Utermohlen, and F Lehmann-Grube
February 1994, Laboratory investigation; a journal of technical methods and pathology,
J Gossmann, and J Lohler, and O Utermohlen, and F Lehmann-Grube
September 2017, Emerging infectious diseases,
J Gossmann, and J Lohler, and O Utermohlen, and F Lehmann-Grube
May 1994, Clinical neurology and neurosurgery,
J Gossmann, and J Lohler, and O Utermohlen, and F Lehmann-Grube
October 2006, Archives of internal medicine,
J Gossmann, and J Lohler, and O Utermohlen, and F Lehmann-Grube
January 1974, Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale,
J Gossmann, and J Lohler, and O Utermohlen, and F Lehmann-Grube
January 1971, Science (New York, N.Y.),
J Gossmann, and J Lohler, and O Utermohlen, and F Lehmann-Grube
November 1946, Journal of immunology (Baltimore, Md. : 1950),
J Gossmann, and J Lohler, and O Utermohlen, and F Lehmann-Grube
August 1969, Applied microbiology,
J Gossmann, and J Lohler, and O Utermohlen, and F Lehmann-Grube
January 2002, Current topics in microbiology and immunology,
J Gossmann, and J Lohler, and O Utermohlen, and F Lehmann-Grube
January 2003, Current topics in microbiology and immunology,
Copied contents to your clipboard!